Emma Louise Sharp
Portfolio Manager-Equities at Evelyn Partners Investment Management LLP
Emma Louise Sharp active positions
Companies | Position | Start | End |
---|---|---|---|
Evelyn Partners Investment Management LLP
Evelyn Partners Investment Management LLP Investment ManagersFinance Evelyn Partners Investment Management LLP (Evelyn Partners) is the investment management subsidiary of Evelyn Partners I M Ltd., which is owned by Platinum LP Guernsey Ltd. in Great Britain. The firm was founded in 1881 and formerly known as Smith & Williamson Investment Management LLP. They changed their name into Evelyn Partners Investment Management LLP when Tilney and Smith & Williamson brands merged into one in 2022. Headquartered in London, Evelyn Partners provides investment management, financial advisory and accountancy services to private clients, professional practices, mid- to large-sized corporations and non-profit organizations. | Portfolio Manager-Equities | 2002-11-30 | - |
Career history of Emma Louise Sharp
Former positions of Emma Louise Sharp
Companies | Position | Start | End |
---|---|---|---|
B.R.A.I.N. Biotechnology Research & Info Network UK Ltd.
B.R.A.I.N. Biotechnology Research & Info Network UK Ltd. BiotechnologyHealth Technology B.R.A.I.N. Biotechnology Research & Info Network UK Ltd. is a private company that supplies bio-based products and solutions. The company is based in Cardiff, UK and has subsidiaries in United Kingdom and United States. It was founded in 2018. | Director/Board Member | 2018-03-16 | 2023-04-13 |
Biocatalysts Ltd.
Biocatalysts Ltd. Pharmaceuticals: OtherHealth Technology Biocatalysts Ltd. operates as a global biotechnology firm producing specialty enzymes at commercial scales for a variety of industries such as food, flavor and fragrance, life science, pharma, and fine chemicals. It offers both off-the-shelf enzyme products and a customized enzyme discovery, development, and manufacturing service. The company was founded in 1983 and is headquartered in Parc Nantgarw, the United Kingdom. | Director/Board Member | 2017-06-18 | 2019-02-28 |
Statistics
International
United Kingdom | 4 |
Operational
Director/Board Member | 2 |
Portfolio Manager-Equities | 1 |
Sectoral
Health Technology | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Evelyn Partners Investment Management LLP
Evelyn Partners Investment Management LLP Investment ManagersFinance Evelyn Partners Investment Management LLP (Evelyn Partners) is the investment management subsidiary of Evelyn Partners I M Ltd., which is owned by Platinum LP Guernsey Ltd. in Great Britain. The firm was founded in 1881 and formerly known as Smith & Williamson Investment Management LLP. They changed their name into Evelyn Partners Investment Management LLP when Tilney and Smith & Williamson brands merged into one in 2022. Headquartered in London, Evelyn Partners provides investment management, financial advisory and accountancy services to private clients, professional practices, mid- to large-sized corporations and non-profit organizations. | Finance |
Biocatalysts Ltd.
Biocatalysts Ltd. Pharmaceuticals: OtherHealth Technology Biocatalysts Ltd. operates as a global biotechnology firm producing specialty enzymes at commercial scales for a variety of industries such as food, flavor and fragrance, life science, pharma, and fine chemicals. It offers both off-the-shelf enzyme products and a customized enzyme discovery, development, and manufacturing service. The company was founded in 1983 and is headquartered in Parc Nantgarw, the United Kingdom. | Health Technology |
B.R.A.I.N. Biotechnology Research & Info Network UK Ltd.
B.R.A.I.N. Biotechnology Research & Info Network UK Ltd. BiotechnologyHealth Technology B.R.A.I.N. Biotechnology Research & Info Network UK Ltd. is a private company that supplies bio-based products and solutions. The company is based in Cardiff, UK and has subsidiaries in United Kingdom and United States. It was founded in 2018. | Health Technology |
- Stock Market
- Insiders
- Emma Louise Sharp
- Experience